Prof Annick Barbaud is an expert in Dermatology at Tenon Hospital (France). As of October 2026, ScienceLeadR ranks Annick Barbaud in the top 1% of experts worldwide for Dermatitis, Sexually Transmitted Diseases and Hypersensitivity. Annick Barbaud has authored 745 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 1,726 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Annick Barbaud Tenon Hospital France
1 726 ScienceLeadR Reputation 1726
Network Map

Dermatology

Subspecialties: Immunology - Pharmacy - Allergy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026

Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 745

Citations

Citations: 9 358 1st author: 61 Last author: 138 Unique author: 28


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Updated EAACI Statement on Drug Hypersensitivity Skin Testing: Methodology and Non-Irritative Concentrations.
PMID 42618976 — skin, research design, pharmaceutical preparations, hypersensitivity, drug hypersensitivity, drug therapy, skin tests, chemotherapy
Allergy20260
Nomenclature on Immune-Mediated Drug Reactions: An EAACI Position Paper.
PMID 42605837 — pharmaceutical preparations, hypersensitivity, drug hypersensitivity, phenotype, immune system
Allergy20261
Increased risk of cutaneous lupus erythematosus flare during the late menopausal transition: A retrospective study of 64 women.
PMID 42436872 — lupus erythematosus, cutaneous, perimenopause, retrospective studies, menopause
JAAD Int20260
Hypersensitivity to Excipients in Drugs: An EAACI Position Paper.
PMID 41952048 — methylcellulose, research design, pharmaceutical preparations, hypersensitivity, drug hypersensitivity, excipients, anaphylaxis, polyethylene glycols
Allergy20260
Immediate and delayed hypersensitivity to biologicals in children-A practical approach: An EAACI task force report.
PMID 41937341 — hypersensitivity, hypersensitivity, delayed, therapeutics, child
Pediatr Allergy Immunol20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2 1
Phase 3 1
Phase 4 1

By status:

Completed 2
Terminated 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map